Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Creating a Routine Set a specific day each week to reconstitute Retatrutide if you use the medication regularly
Mon-Fri: 9:00 AM 9:00 PM Sat-Sun: 10:00 AM 6:00 PM Mon-Fri: 9:00 AM 9:00 PM Sat-Sun: 10:00 AM 6:00 PM Begin with a medical consultation and evaluation with our Nurse Practitioner to ensure youre a great candidate for the program
I have so much more energy and focus
Health-conscious individuals trust Elase to explore treatments that fit their lifestyle and wellness goals
US$ 29.08
US$ 28.62
US$ 20.07
